Skip to main content

Table 4 Hospitalisation outcome measures and results

From: The use of technology to improve medication adherence in heart failure patients: a systematic review of randomised controlled trials

Study

Clinical outcomes

Results

P-value(s)

Hale et al. [15], USA

Hospitalisations

ED visits

Number of participants who had one or more HF-related hospitalisations were 4 in intervention group versus 1 in control group and non-HF related hospitalisations were 1 in intervention group versus 4 in control group after 90 days. All-cause hospital admissions were significant, with 1 in intervention group versus 4 in control group

Number of participants who had one or more HF-related ED visits were 1 in intervention group versus 3 in control group and non-HF related ED visits were 3 in intervention group versus 4 in control group after 90 days. All-cause ED visits were not significant, with 3 in the intervention group versus 6 in the control group

0.340 (HF), 0.340 (non-HF), 0.040 (all-cause)

0.600 (HF), 0.990 (non-HF), 0.680 (all-cause)

Gallagher et al. [16], USA

30-day all cause readmission

Number of readmissions were 6 in the intervention group and 4 in the control group after 30 days follow-up

0.720

Wu et al. [19], USA

Cardiac event-free survival

(Including ED visit, hospitalization, death)

Event-free survival was significantly longer for the patients in both intervention groups than the control

0.010

Yanicelli et al. [21], Argentina

Rehospitalisation (from electronic medical record)

Number of rehospitalisation were 0 for intervention group and 2 in control group after 3 months follow-up

0.500

Young et al. [22], USA

All-cause readmissions

ED visits

Number of participants readmitted to hospital was 10 for intervention group versus 3 in the control group

Number of participants admitted for ED visits at 90 days were 9 for intervention group versus 11 in control group

0.088

  1. Bolded p-values represent the significance values used as part of the synthesis. For fairness of comparison, all-cause hospitalisation was used in Hale et al, to encompass all hospitalisations regardless of their relation to heart failure